Table 6.
Acute GI and GU Toxicity at the Time of Completion of SBRT According to CTCAE Criteria.
| Acute GI Toxicity | Acute GU Toxicity | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Grade | 0 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | |
| Zilli et al 19 | 43% | 43% | 14% | 0% | 0% | 14% | 14% | 72% | 0% | 0% |
| Vavassori et al 20 | “After a median follow-up of 11.3 months none of the patients had developed severe urinary or rectal acute toxicity” | |||||||||
| Zerini et al 21 | 88% | 6% | 3% | 0% | 0% | 75% | 19% | 6% | 0% | 0% |
| Fuller et al 22 | 100% | 0% | 0% | 0% | 97% | 0% | 3% | 0% | ||
| Janoray et al 23 | 90% | 10% | 0% | 0% | 0% | 81% | 14% | 5% | 0% | 0% |
| Mbeutcha24 | 72% | 6% | 11% | 0% | 0% | 44% | 28% | 17% | 6% | 0% |
| Miszczyk et al | 97% | 3% | 0% | 0% | 0% | 79% | 16% | 5% | 0% | 0% |
Abbreviations: GI, gastrointestinal; GU, genitourinary; SABR, stereotactic ablative radiotherapy.
The toxicity in our work was assessed according EORTC/RTOG grading system.